In 2020, Chen and colleagues elucidated a mechanism by which IRAK1 promotes metastasis in hepatocellular carcinoma (HCC) through the activation of the NLRP3/MAPKs/IL-1β pathway [71]. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.